학술논문

Phase I and pharmacokinetic study of DX-8951f, a novel topoisomerase I inhibitor, using a 30 minute infusion weekly x 3 every 4 weeks
Document Type
Journal
Source
ANNALS OF ONCOLOGY; 1998, 9 p65-p65, 1p. Supplement: 2
Subject
Language
English
ISSN
09237534